These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25999911)

  • 21. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
    Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
    Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Panel of Plasma Biomarkers for Differential Diagnosis of Parkinsonian Syndromes.
    Li Q; Li Z; Han X; Shen X; Wang F; Bai L; Li Z; Zhang R; Wang Y; Zhu X
    Front Neurosci; 2022; 16():805953. PubMed ID: 35250451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia.
    Abdo WF; van de Warrenburg BP; Munneke M; van Geel WJ; Bloem BR; Kremer HP; Verbeek MM
    Neurology; 2006 Aug; 67(3):474-9. PubMed ID: 16894110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
    JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach.
    Marques TM; van Rumund A; Kersten I; Bruinsma IB; Wessels HJCT; Gloerich J; Kaffa C; Esselink RAJ; Bloem BR; Kuiperij HB; Verbeek MM
    NPJ Parkinsons Dis; 2021 Nov; 7(1):107. PubMed ID: 34848724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.
    Abu-Rumeileh S; Capellari S; Stanzani-Maserati M; Polischi B; Martinelli P; Caroppo P; Ladogana A; Parchi P
    Alzheimers Res Ther; 2018 Jan; 10(1):3. PubMed ID: 29368621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders.
    Hall S; Janelidze S; Surova Y; Widner H; Zetterberg H; Hansson O
    Sci Rep; 2018 Sep; 8(1):13276. PubMed ID: 30185816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis.
    Cong S; Xiang C; Wang H; Cong S
    J Neurol; 2021 Aug; 268(8):2703-2712. PubMed ID: 32162061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson's disease.
    Xiang C; Cong S; Tan X; Ma S; Liu Y; Wang H; Cong S
    NPJ Parkinsons Dis; 2022 Nov; 8(1):165. PubMed ID: 36446820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal Fluid Biomarkers in Multiple System Atrophy Relative to Parkinson's Disease: A Meta-Analysis.
    Xie D; Feng L; Huang H; Zhao Q; Ning P; Shen Q; Lu H; Xu F; Xu Y
    Behav Neurol; 2021; 2021():5559383. PubMed ID: 34158872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
    Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM
    Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
    Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased CSF NFL in Non-demented Parkinson's Disease Subjects Reflects Early White Matter Damage.
    Papuć E; Rejdak K
    Front Aging Neurosci; 2020; 12():128. PubMed ID: 32477099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with
    Sheng ZH; Ma LZ; Liu JY; Ou YN; Zhao B; Ma YH; Tan L
    Front Aging Neurosci; 2022; 14():1061096. PubMed ID: 36589544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Head-to-head comparison of 6 plasma biomarkers in early multiple system atrophy.
    Guo Y; Shen XN; Huang SY; Chen SF; Wang HF; Zhang W; Zhang YR; Cheng W; Cui M; Dong Q; Yu JT
    NPJ Parkinsons Dis; 2023 Mar; 9(1):40. PubMed ID: 36922526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
    Brettschneider J; Petzold A; Süssmuth SD; Landwehrmeyer GB; Ludolph AC; Kassubek J; Tumani H
    Mov Disord; 2006 Dec; 21(12):2224-7. PubMed ID: 17013909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes.
    Starhof C; Hejl AM; Heegaard NHH; Carlsen AL; Burton M; Lilje B; Winge K
    Mov Disord; 2019 Feb; 34(2):246-254. PubMed ID: 30557454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Midbrain and pons MRI shape analysis and its clinical and CSF correlates in degenerative parkinsonisms: a pilot study.
    Painous C; Pascual-Diaz S; Muñoz-Moreno E; Sánchez V; Pariente JC; Prats-Galino A; Soto M; Fernández M; Pérez-Soriano A; Camara A; Muñoz E; Valldeoriola F; Caballol N; Pont-Sunyer C; Martin N; Basora M; Tio M; Rios J; Martí MJ; Bargalló N; Compta Y
    Eur Radiol; 2023 Jul; 33(7):4540-4551. PubMed ID: 36773046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.